FDA Drug Approvals - 2026-09-27
FDA drug approvals recorded by openFDA between 2026-09-13 and 2026-09-27, newest first. Company is the first listed manufacturer; tickers link to Seeking Alpha. Approval Date Company Drug Ticker 2026-09-22 Alembic Pharmaceuticals Limited TELMISARTAN AND AMLODIPINE n/a 2026-09-22 Amici Pharma, Inc. RISPERIDONE n/a 2026-09-22 Bayer HealthCare Pharmaceuticals Inc. NUBEQA BAYRY 2026-09-22 Eugia US LLC KETAMINE HYDROCHLORIDE n/a 2026-09-22 GLENMARK PHARMACEUTICALS INC., USA EPINEPHRINE n/a 2026-09-22 Novartis Pharmaceuticals Corporation SCEMBLIX NVS 2026-09-21 Merck Sharp & Dohme LLC WINREVAIR MRK 2026-09-18 AMNEAL LANREOTIDE ACETATE AMNL 2026-09-18 BAXTER HLTHCARE CORP ROCURONIUM BROMIDE BAX 2026-09-18 Eli Lilly and Company INLURIYO LLY 2026-09-18 Eli Lilly and Company VERZENIO LLY 2026-09-18 HIKMA DEFLAZACORT n/a 2026-09-18 INTRABIO AQNEURSA n/a 2026-09-18 Ipsen Biopharmaceuticals, Inc. SOHONOS n/a 2026-09-18 Trifluent Pharma LLC DICLOFENAC POTASSIUM n/a 2026-09-17 Actavis Pharma, Inc. DEXTROAMPHETAMINE SULFATE n/a 2026-09-17 Alembic Pharmaceuticals Limited CLONIDINE HYDROCHLORIDE n/a 2026-09-17 APOTEX LEVOCETIRIZINE DIHYDROCHLORIDE n/a 2026-09-17 Apotex Corp ICOSAPENT ETHYL n/a 2026-09-17 AUROBINDO PHARMA LTD CYCLOSPORINE n/a 2026-09-17 CIPLA CALCIUM GLUCONATE IN SODIUM CHLORIDE n/a 2026-09-17 FRESENIUS KABI USA DAPTOMYCIN n/a 2026-09-17 JANSSEN PHARMS SPRAVATO JNJ 2026-09-17 LUPIN AMABELZ n/a 2026-09-17 Teva Parenteral Medicines, Inc. PALONOSETRON HYDROCHLORIDE TEVA 2026-09-17 Zydus Pharmaceuticals USA Inc. LACOSAMIDE n/a 2026-09-16 American Health Packaging GABAPENTIN AHR 2026-09-16 ASTRAZENECA TRUQAP AZN 2026-09-16 Aurobindo Pharma Limited MELOXICAM n/a 2026-09-16 Bayer HealthCare Pharmaceuticals Inc. KERENDIA BAYRY 2026-09-16 Chartwell RX, LLC CALCITRIOL n/a 2026-09-16 Fresenius Kabi USA, LLC GLUCAGON n/a 2026-09-16 Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. TRANEXAMIC ACID HRTG 2026-09-16 Macleods Pharmaceuticals Limited OLANZAPINE n/a 2026-09-16 Novartis Pharmaceuticals Corporation ZORTRESS NVS 2026-09-16 NUVATION IBTROZI NUVB 2026-09-16 STRIDES PHARMA DEXTROAMPHETAMINE SULFATE n/a 2026-09-16 U.S. Pharmaceuticals XELJANZ n/a 2026-09-16 U.S. Pharmaceuticals XELJANZ XR n/a 2026-09-15 ACTAVIS TOTOWA LETROZOLE n/a 2026-09-15 CHARTWELL RX PRAMIPEXOLE DIHYDROCHLORIDE n/a 2026-09-15 DIFGEN PHARMS EPINEPHRINE n/a 2026-09-15 MACLEODS PHARMS MILNACIPRAN HYDROCHLORIDE n/a 2026-09-15 Meitheal Pharmaceuticals Inc. GARZULYS n/a 2026-09-15 Meitheal Pharmaceuticals Inc. TIGECYCLINE n/a 2026-09-15 Mylan Pharmaceuticals Inc. AMNESTEEM VTRS 2026-09-15 Otsuka America Pharmaceutical, Inc. JYNARQUE n/a 2026-09-15 Sandoz Inc TIGECYCLINE SDZWF 2026-09-15 STRIDES PHARMA MILNACIPRAN HYDROCHLORIDE n/a 2026-09-15 SUN PHARM INDUSTRIES DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE n/a 2026-09-15 TEVA PHARMS CARBAMAZEPINE TEVA 2026-09-15 Upsher-Smith Laboratories, LLC TESTOSTERONE n/a 2026-09-15 ZYDUS LIFESCIENCES TRETINOIN n/a 2026-09-14 AJANTA PHARMA LTD HALOPERIDOL n/a 2026-09-14 Alembic Pharmaceuticals Inc. ITRACONAZOLE n/a 2026-09-14 ALVOGEN PRIMAQUINE PHOSPHATE n/a 2026-09-14 Amneal Pharmaceuticals LLC ITRACONAZOLE AMNL 2026-09-14 ASTRAZENECA TAGRISSO AZN 2026-09-14 AUROLIFE PHARMA LLC BECLOMETHASONE DIPROPIONATE n/a 2026-09-14 Cranbury Pharmaceuticals, LLC DOXYCYCLINE HYCLATE n/a 2026-09-14 CURIUM BEXLUTRY n/a 2026-09-14 GENENTECH INC EVRYSDI RHHBY 2026-09-14 Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. COLISTIMETHATE SODIUM HRTG 2026-09-14 Micro Labs Limited CLOBAZAM n/a 2026-09-14 SAGENT PHARMS INC COLISTIMETHATE SODIUM n/a 2026-09-14 Unichem Pharmaceuticals (USA), Inc. PRIMAQUINE PHOSPHATE n/a 2026-09-14 VistaPharm, LLC METHADONE HYDROCHLORIDE n/a 2026-09-14 Xiromed LLC NEOSTIGMINE METHYLSULFATE n/a 2026-09-14 ZYDUS LIFESCIENCES LETROZOLE n/a 2026-09-14 ZYDUS PHARMS EPINEPHRINE n/a Only the 70 most relevant rows are shown. Approved applications (originals and supplements) in this window: 73; rows shown: 70; tickers identified: 22. Known pharma subsidiaries are mapped to their US-listed parent or ADR (e.g. Janssen -> JNJ, Novartis -> NVS). Companies shown as “n/a” are mostly foreign or privately held drug makers (mostly generics) with no US-listed stock. ...